Neuralstem climbs as drug indexes hug flat line

Shares of Neuralstem rally on news that U.S. regulators gave the company a green light to begin testing of its new antidepressant drug.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.